Oliver Gross

21PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersInfant and child healthCell physiologyNephrology and urologyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 15, 2026
Albuminuria drives hyperlipidemia in patients with Alport syndrome.

|May 05, 2025
Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease.

Kathrin Burgmaier, Bénédicte Buffin-Meyer, Julie Klein

|Dec 14, 2024
Diagnosis, management and treatment of the Alport syndrome - 2024 guideline on behalf of ERKNet, ERA and ESPN.

Roser Torra, Beata Lipska-Zietkiewicz, Frederic Acke

|Sep 14, 2024
Preclinical Detection of Early Glomerular Injury in Children with Kidney Diseases-Independently of Usual Markers of Kidney Impairment and Inflammation.

Heidrun Rhode, Baerbel Tautkus, Friederike Weigel

|Aug 09, 2024
Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport.

Oliver Gross, Jan Boeckhaus, Lutz T Weber

Pageof 4